NASDAQ:PDSB

Pds Biotechnology Stock Forecast

etoro logo Buy PDSB
*Your capital is at risk
$0.735
+0.0237 (+3.33%)
At Close: Jul 17, 2026
AI Analysis AI Analysis of PDSB AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add PDSB to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Stronger technical forecast for PDS Biotechnology Corp. stock price after Friday trading
(Updated on Jul 17, 2026)

Sell candidate since Jul 16, 2026 Gain 3.33%

The PDS Biotechnology Corp. stock price gained 3.33% on the last trading day (Friday, 17th Jul 2026), rising from $0.711 to $0.735. During the last trading day the stock fluctuated 4.74% from a day low at $0.709 to a day high of $0.742. The price has fallen in 8 of the last 10 days and is down by -13.86% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 95 thousand more shares were traded than the day before. In total, 251 thousand shares were bought and sold for approximately $184.22 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -26.12% during the next 3 months and, with a 90% probability hold a price between $0.386 and $0.85 at the end of this 3-month period.

PDSB Signals & Forecast

There are mixed signals in the stock today. The PDS Biotechnology Corp. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.750 and $0.93. A break-up above any of these levels will issue buy signals. A buy signal was issued from a pivot bottom point on Thursday, July 16, 2026, and so far it has risen 3.33%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). PDS Biotechnology Corp. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk.

Support, Risk & Stop-loss for PDS Biotechnology Corp. stock

PDS Biotechnology Corp. finds support from accumulated volume at $0.711 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.0336 between high and low, or 4.74%. For the last week, the stock has had daily average volatility of 5.73%.

PDS Biotechnology Corp. is oversold on RSI14 (17). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (PDSB) For The Upcoming Trading Day Of Monday 20th

For the upcoming trading day on Monday, 20th we expect PDS Biotechnology Corp. to open at $0.729, and during the day (based on 14 day Average True Range), to move between $0.698 and $0.772, which gives a possible trading interval of +/-$0.0734 (+/-10.51%) up or down from last closing price. If PDS Biotechnology Corp. takes out the full calculated possible swing range there will be an estimated 10.51% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.711 (3.22%) than the resistance at $0.787 (7.12%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is PDS Biotechnology Corp. stock A Buy?

PDS Biotechnology Corp. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

Current score: -3.693 Sell Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on July 20, 2026 - $0.729 ( 0.85%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

PDSB Performance

Trading levels for PDSB

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 0.762 3.72%
R2 0.749 1.97%
R1 0.741 0.89%
Price 0.735
S1 0.716 -2.60%
S2 0.708 -3.68%
S3 0.695 -5.42%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0.91 23.69%
R2 0.90 22.53%
R1 0.787 7.12%
Price 0.735
S1 0.711 -3.22%
S2 0 -
S3 0 -

FAQ

What is the symbol for PDS Biotechnology Corp. Stock and on which exchange is it traded?
The symbol for PDS Biotechnology Corp. is PDSB and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell PDS Biotechnology Corp. Stock?
PDS Biotechnology Corp. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

How to buy PDS Biotechnology Corp. Stock?
PDS Biotechnology Corp. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy PDS Biotechnology Corp. Stock.

What's the current price of PDS Biotechnology Corp. Stock?
As of the end of day on the Jul 17, 2026, the price of an PDS Biotechnology Corp. (PDSB) share was $0.735.

What is the 52-week high and low for PDS Biotechnology Corp. Stock?
The 52-week high for PDS Biotechnology Corp. Stock is $1.55 and the 52-week low is $0.520.

What is the market capitalization of PDS Biotechnology Corp. Stock?
As of the Jul 17, 2026, the market capitalization of PDS Biotechnology Corp. is 41.097M.

When is the next earnings date for PDS Biotechnology Corp.?
The upcoming earnings date for PDS Biotechnology Corp. is Aug 12, 2026.
Click to get the best stock tips daily for free!
ABOUT PDS BIOTECHNOLOGY CORP.
PDS Biotechnology
PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies, and cervical cancer. The company is also developing various product candidates, which are in preclini...
GOLDEN STAR
Ticker Change Signal Date
DHT
$17.31
0.578% Jul 13
SRPT
$17.02
1.18% Jun 29
JLL
$299.78
10.30% Jun 24
NMRK
$15.02
3.86% Jun 24
CAG
$13.43
6.29% Jun 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE